Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cancer Cytopathol. 2018 Feb 16;126(5):326–335. doi: 10.1002/cncy.21982

Table 4.

Comparison of G2, WD-G3, and PD neuroendocrine neoplasm cytologic features

Well
differentiated
G2
Well
differentiated
G3
Poorly
differentiated
P value
Total (n=65) 19 32 14
Ki67% median (range) 11% (3.2–17) 40% (21–89) 62% (25–95) <.001
Large nuclear size No. (%) 0 (0) 3 (9) 2 (14) .2
Nuclear pleomorphism No. (%) 1 (5) 4 (13) 7 (50) .004
Round nucleus No. (%) 14 (74) 19 (59) 3 (21) .01
Smooth nucleus contour No. (%) 18 (95) 30 (94) 9 (64) .02
Angulated nuclei No. (%) 3 (21) 12 (38) 12 (87) <.001
Fine chromatin No. (%) 3 (15) 3 (4) 1 (7) .8
Single prominent nucleolus No. (%) 1 (5) 4 (13) 2 (14) .6
Plasmacytoid morphology No. (%) 16 (84) 24 (75) 1 (7) <.001
Abundant cytoplasm No. (%) 11 (17) 23 (72) 3 (21) .007
Nuclear tangles No. (%) 8 (42) 24 (75) 13 (93) .006
Molding No. (%) 1 (5) 3 (9) 11 (79) <.001
Apoptosis No. (%)
     Present 11 (58) 28 (86) 14 (100) .005
     >5/ 10 hpf 3 (18) 14 (44) 11 (79) .001
Mitoses No. (%)
    Present 10 (27) 18 (56) 9 (64) .8
    >5/10 hpf 1 (5) 6 (3) 6 (43) .03
Necrosis 0 (0) 4 (13) 6 (43) .003